11.21
0.18%
0.02
After Hours:
11.17
-0.04
-0.36%
Clearpoint Neuro Inc stock is traded at $11.21, with a volume of 158.65K.
It is up +0.18% in the last 24 hours and down -13.64% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$11.19
Open:
$11.09
24h Volume:
158.65K
Relative Volume:
0.66
Market Cap:
$303.55M
Revenue:
$23.96M
Net Income/Loss:
$-22.09M
P/E Ratio:
-13.19
EPS:
-0.85
Net Cash Flow:
$-14.77M
1W Performance:
-2.78%
1M Performance:
-13.64%
6M Performance:
+64.85%
1Y Performance:
+123.75%
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-16-23 | Resumed | B. Riley Securities | Buy |
Apr-05-22 | Resumed | B. Riley Securities | Buy |
Mar-18-21 | Initiated | Lake Street | Buy |
Jul-17-20 | Initiated | B. Riley FBR | Buy |
Clearpoint Neuro Inc Stock (CLPT) Latest News
Point72 Asia Singapore Pte. Ltd. Makes New Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
(CLPT) Investment Analysis and Advice - Stock Traders Daily
Believ acquires’ SMS Public EV Charging to accelerate charge point rollout - Fleet World
FDA Clears Neuroblade System For Minimally Invasive Neurosurgery - MPO-mag
The Good News and Bad News From ChargePoint's Q2 Results - sharewise
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28% - Simply Wall St
It makes sense and dollars to buy ClearPoint Neuro Inc (CLPT) stock - SETE News
Is ClearPoint Neuro Inc (CLPT) a good investment opportunity? - US Post News
57,015 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Purchased by Rinkey Investments - MarketBeat
Clearpoint Neuro shares target raised by Lake Street with Buy rating - Investing.com
Lake Street Capital Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $15.00 - Defense World
Lake Street Capital Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $15.00 - MarketBeat
ClearPoint Neuro announces early repayment of convertible note - Medical Buyer
ClearPoint Neuro Announces Early Repayment of $10 Million Note - ForexTV.com
ClearPoint Neuro repays $10 million note ahead of schedule - Investing.com
ClearPoint Neuro Preempts Convertible Note Obligations - TipRanks
ClearPoint Neuro Announces Early Repayment of $10 Million Note - GlobeNewswire
ClearPoint Neuro Announces Early Repayment of $10 Million Note - StockTitan
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in July - MarketBeat
Short Interest in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Drops By 5.9% - Defense World
Price T Rowe Associates Inc. MD Acquires 1,813 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load? - Simply Wall St
ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade) - Seeking Alpha
B. Riley Analysts Cut Earnings Estimates for ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro, Inc. Expected to Post Q3 2024 Earnings of ($0.19) Per Share (NASDAQ:CLPT) - Defense World
Riding the Waves: A Guide to Investing in CLPT Stock - The InvestChronicle
ClearPoint Neuro: My Favorite Growth Stock (NASDAQ:CLPT) - Seeking Alpha
Earnings call: ClearPoint Neuro sees record revenue of $7.9 million By Investing.com - Investing.com Canada
Earnings call: ClearPoint Neuro sees record revenue of $7.9 million - Investing.com
Earnings call: ClearPoint Neuro sees record revenue of $7.9 million By Investing.com - Investing.com UK
ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript - Seeking Alpha
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
ClearPoint Neuro Reports Second Quarter 2024 Results - StockTitan
ClearPoint Neuro Reports Second Quarter 2024 Results - GlobeNewswire
Financial Review: TriSalus Life Sciences (NASDAQ:TLSI) & ClearPoint Neuro (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) to Release Earnings on Wednesday - American Banking and Market News
Russell Investments Group Ltd. Grows Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro, Inc. (CLPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
ClearPoint Neuro (CLPT) Set to Announce Earnings on Wednesday - MarketBeat
ClearPoint Neuro (CLPT) Scheduled to Post Quarterly Earnings on Wednesday - Defense World
Equities Analysts Set Expectations for ClearPoint Neuro, Inc.’s Q2 2024 Earnings (NASDAQ:CLPT) - Defense World
B. Riley Weighs in on ClearPoint Neuro, Inc.'s Q2 2024 Earnings (NASDAQ:CLPT) - MarketBeat
The 3 Best Brain-Computer Interface Stocks to Buy Now - InvestorPlace
Short Interest in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Decreases By 37.5% - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Now Covered by Analysts at B. Riley - Defense World
(CLPT) Trading Report - Stock Traders Daily
B. Riley Begins Coverage on ClearPoint Neuro (NASDAQ:CLPT) - MarketBeat
Short Interest in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Grows By 9.6% - Defense World
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 - GlobeNewswire
Where are the Opportunities in (CLPT) - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):